Interestingly, we found that the sensitivity of ESCC cells to LSD1 or G9a inhibitor was not related to the expression levels of either LSD1 or G9a (Figure S1c-d). This evidence concerns the gene EHMT2 and esophageal squamous cell carcinoma.